Janssen vaccine maker considers closing Bern factory

Published on July 2, 2025

See on Internet Archive

by
Swissinfo
My articles My site About me My videos My books
Follow on:Twitter Facebook Google +

Vaccine developer Janssen is considering closing its factory in the Swiss capital Bern. On Tuesday it opened a consultation procedure with employees to find alternatives. Up to 300 employees could be affected by a plant closure. +Get the most important news from Switzerland in your inbox The subsidiary of US pharmaceutical giant Johnson & Johnson said on Tuesday that it was considering closing the Bern plant for two reasons. Firstly, a new vaccine designed to prevent colibacillus infections is not as effective as hoped. Secondly, the production of lentiviral vectors will soon cease in Bern. The global company Johnson & Johnson is about to inaugurate a new, much larger plant in the Netherlands, according to a press release. The factory that houses Janssen’s operations in Bern has a long history. It was founded in 1898 as the Swiss Institute of Serotherapy and Vaccination. Translated from German by DeepL/jdp How we work We select the most relevant news for an international audience ... Full story here Are you the author?

About Swissinfo

SWI swissinfo.ch – the international service of the Swiss Broadcasting Corporation (SBC). Since 1999, swissinfo.ch has fulfilled the federal government’s mandate to distribute information about Switzerland internationally, supplementing the online offerings of the radio and television stations of the SBC. Today, the international service is directed above all at an international audience interested in Switzerland, as well as at Swiss citizens living abroad.

My articles My site About me My books
Follow on:Twitter Facebook Google +